{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:40:57Z","timestamp":1788482457772,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T00:00:00Z","timestamp":1531440000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012752","name":"Elanco Animal Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-2967-5","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T08:27:38Z","timestamp":1531384058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio\u2122) in controlling ticks in client-owned cats in Europe"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-2146","authenticated-orcid":false,"given":"Daniela","family":"Cavalleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Seewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Nanchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,13]]},"reference":[{"key":"2967_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-3305-5-8","volume":"5","author":"TG Jaenson","year":"2012","unstructured":"Jaenson TG, Jaenson DG, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors. 2012;5:8.","journal-title":"Parasit Vectors."},{"key":"2967_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5604\/12321966.1203889","volume":"23","author":"Z Zaj\u0105c","year":"2016","unstructured":"Zaj\u0105c Z, Katarzyna B, Buczek A. Factors influencing the distribution and activity of Dermacentor reticulatus (F.) ticks in an anthropopressure-unaffected area in central-eastern Poland. Ann Agric Environ Med. 2016;23:270\u20135.","journal-title":"Ann Agric Environ Med."},{"key":"2967_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13071-016-1599-x","volume":"9","author":"G F\u00f6ldv\u00e1ri","year":"2016","unstructured":"F\u00f6ldv\u00e1ri G, \u0160irok\u00fd P, Szekeres S, Majoros G, Sprong H. Dermacentor reticulatus: a vector on the rise. Parasit Vectors. 2016;9:314.","journal-title":"Parasit Vectors."},{"issue":"Suppl. 37","key":"2967_CR4","first-page":"5","volume":"293","author":"SE Randolph","year":"2004","unstructured":"Randolph SE. Evidence that climate change has caused \u2018emergence\u2019 of tick borne diseases in Europe? Int J Med Microbiol. 2004;293(Suppl. 37):5\u201315.","journal-title":"Int J Med Microbiol."},{"key":"2967_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/jme\/tjv005","volume":"52","author":"AL Eiden","year":"2015","unstructured":"Eiden AL, Kaufman PE, Oi FM, Allan SA, Miller RJ. Detection of permethrin resistance and fipronil tolerance in Rhipicephalus sanguineus (Acari: Ixodidae) in the United States. J Med Entomol. 2015;52:429\u201336.","journal-title":"J Med Entomol."},{"key":"2967_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbrc.2009.11.131","volume":"391","author":"Y Ozoe","year":"2010","unstructured":"Ozoe Y, Asahi M, Ozoe F, Nakahira K, Mita T. The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels. Biochem Biophys Res Commun. 2010;391:744\u20139.","journal-title":"Biochem Biophys Res Commun."},{"key":"2967_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.vetpar.2014.02.020","volume":"201","author":"WL Shoop","year":"2014","unstructured":"Shoop WL, Hartline EJ, Gould BR, Waddell ME, McDowell RG, Kinney JB, et al. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs. Vet Parasitol. 2014;201:179\u201389.","journal-title":"Vet Parasitol."},{"key":"2967_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.vetpar.2016.02.019","volume":"222","author":"TL McTier","year":"2016","unstructured":"McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. Discovery of sarolaner: A novel, orally administered, broad-spectrum. isoxazoline ectoparasiticide for dogs. Vet Parasitol. 2016;222:3\u201311.","journal-title":"isoxazoline ectoparasiticide for dogs. Vet Parasitol."},{"key":"2967_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1186\/s13071-017-2471-3","volume":"10","author":"SE Little","year":"2017","unstructured":"Little SE. Lotilaner - a novel systemic tick and flea control product for dogs. Parasit Vectors. 2017;10:539.","journal-title":"Parasit Vectors."},{"key":"2967_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s13071-017-2467-z","volume":"10","author":"M Murphy","year":"2017","unstructured":"Murphy M, Cavalleri D, Seewald W, Drake J, Nanchen S. Laboratory evaluation of the speed of kill of lotilaner (Credelio\u2122) against Ixodes ricinus ticks on dogs. Parasit Vectors. 2017;10:541.","journal-title":"Parasit Vectors."},{"key":"2967_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s13071-017-2477-x","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Lizundia Gorbea R, Seewald W, Drake J, Nanchen S. Laboratory evaluations of the immediate and sustained effectiveness of lotilaner (Credelio\u2122) against three common species of ticks affecting dogs in Europe. Parasit Vectors. 2017;10:527.","journal-title":"Parasit Vectors."},{"key":"2967_CR12","unstructured":"European Medicines Agency. Committee for Medicinal Products for Veterinary Use, Bravecto\u00ae European Product Information. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/veterinary\/002526\/WC500163859.pdf\n                    \n                  . Accessed 23 March 2018."},{"key":"2967_CR13","unstructured":"European Medicines Agency. Committee for Medicinal Products for Veterinary Use, Stronghold\u00ae Plus, European Product Information. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/veterinary\/004194\/WC500222781.pdf\n                    \n                  . Accessed 23 March 2018."},{"key":"2967_CR14","doi-asserted-by":"crossref","unstructured":"Kuntz E, Kammanadiminti S. Safety of lotilaner flavoured chewable tablets (Credelio TM) after oral administration in cats. Parasit Vectors. 2018; (In press)","DOI":"10.1186\/s13071-018-2969-3"},{"key":"2967_CR15","doi-asserted-by":"crossref","unstructured":"Cavalleri D, Murphy M, Seewald W, Nanchen S. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio\u2122) in controlling fleas in client-owned cats in Europe. Parasit Vectors. 2018; (In press)","DOI":"10.1186\/s13071-018-2971-9"},{"key":"2967_CR16","doi-asserted-by":"crossref","unstructured":"Cavalleri D, Murphy M, Seewald W, Nanchen S. Laboratory evaluation of the efficacy and speed of kill of lotilaner (Credelio\u2122) against Ctenocephalides felis on cats. Parasit Vectors. 2018; (In press)","DOI":"10.1186\/s13071-018-2972-8"},{"key":"2967_CR17","doi-asserted-by":"crossref","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. Laboratory evaluation of the efficacy and speed of kill of lotilaner (CredelioTM) against Ixodes ricinus ticks on cats. Parasit Vectors. 2018; (In press)","DOI":"10.1186\/s13071-018-2968-4"},{"key":"2967_CR18","unstructured":"The Rules Governing Medicinal Products in the European Union. Volume VIIA: Guidelines for the testing of veterinary medicinal products: Demonstration of Efficacy of Ectoparasiticides, 7AE17a. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004662.pdf\n                    \n                  . Accessed 21 March 2018."},{"key":"2967_CR19","unstructured":"European Medicines Agency. Committee for Medicinal Products for Veterinary Use, EMA\/CVMP\/EWP\/206024\/2011: Guideline on the demonstration of palatability of veterinary medicinal products. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/07\/WC500170030.pdf\n                    \n                  . Accessed 21 Mar 2018."},{"key":"2967_CR20","unstructured":"European Medicines Agency. Committee for Medicinal Products for Veterinary Use, \/CVMP\/EWP\/005\/2000-Rev.2: Guideline for the testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of tick and flea infestation in dogs and cats. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004596.pdf\n                    \n                  . Accessed 21 Mar 2018."},{"key":"2967_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.vetpar.2013.02.003","volume":"194","author":"AA Marchiondo","year":"2013","unstructured":"Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE, Dryden MW. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol. 2013;194:84\u201397.","journal-title":"Vet Parasitol."},{"key":"2967_CR22","unstructured":"Veterinary Medicines Directorate. Eliminall\u00ae 50 mg spot-on solution for cats, Summary of Product Characteristics (SPC). \n                    http:\/\/www.vmd.defra.gov.uk\/ProductInformationDatabase\/SPC_Documents\/SPC_339506.doc\n                    \n                  . Accessed 22 March 2018."},{"key":"2967_CR23","unstructured":"Frontline Combo\u00ae Spot-on Cat, Summary of Product Characteristics (SPC). \n                    http:\/\/mri.cts-mrp.eu\/Veterinary\/Product\/Details\/805\n                    \n                  . Accessed 27 Mar 2018."},{"key":"2967_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12868-015-0170-6","volume":"16","author":"MM Sandau","year":"2015","unstructured":"Sandau MM, Goodman JR, Thomas A, Bucker JB. Rawson NE. A functional comparison of the domestic cat bitter receptors Tas2r38 and Tas2r43 with their human orthologs. BMC Neurosci. 2015;16:33.","journal-title":"BMC Neurosci"},{"key":"2967_CR25","unstructured":"International Cat Care's owner advice information. \n                    https:\/\/icatcare.org\/advice\/how-give-your-cat-tablet\n                    \n                  . Accessed 23 Mar 2018."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-2967-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-2967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:17:44Z","timestamp":1562959064000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-2967-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2967"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-2967-5","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,13]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Sponsor Global Animal Welfare Group. Participating cat owners were required to sign an informed consent form for their cat(s) to participate in the study, after details of the study design and products under investigation had been explained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DC, MM, WSo and Steve Nanchen are employees of Elanco Animal Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"411"}}